Reality is Far From the Guidelines, When it Comes to Stroke Prevention in Atrial Fibrillation

Kathryn D. Tiver, Jing Quah, Dhani Dharmaprani, Anand N. Ganesan

Research output: Contribution to journalEditorial

Abstract

In this issue of Heart, Lung and Circulation, Hutchens et al. report the trends of oral anticoagulant use and antiplatelet use in patients with atrial fibrillation (AF).

Alarmingly, by the end of the study, only 45% of high-risk patients, in whom the guidelines currently recommend oral anticoagulation (OAC) therapy, were receiving OAC therapy. This seems surprising, compared to what we perceive the rates to be in our own cardiology practice...
Original languageEnglish
Pages (from-to)935-936
Number of pages2
JournalHeart, Lung and Circulation
Volume30
Issue number7
DOIs
Publication statusPublished - Jul 2021

Keywords

  • Antiplatelet agents
  • Atrial fibrillation
  • Guidelines
  • Oral anticoagulants
  • Stroke prevention

Fingerprint

Dive into the research topics of 'Reality is Far From the Guidelines, When it Comes to Stroke Prevention in Atrial Fibrillation'. Together they form a unique fingerprint.

Cite this